Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03497767 |
|---|---|
| Brief Title: | A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases (OUTRUN) |
| First Submitted : | February 26, 2018 |
| First Submitted that Met QC Criteria : | April 12, 2018 |
| First Posted : | April 13, 2018 |
| Last Update Submitted that Met QC Criteria : | November 16, 2022 |
| Last Update Posted : | November 21, 2022 |